Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;96(9):E1466-71.
doi: 10.1210/jc.2011-0228. Epub 2011 Jun 29.

Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease

Affiliations

Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease

Susan Hutfless et al. J Clin Endocrinol Metab. 2011 Sep.

Abstract

Introduction: Antibodies to thyroglobulin (Tg), thyroperoxidase (TPO), and TSH receptor (TSH-R) are prevalent in autoimmune thyroid diseases. We aimed to assess whether females with Graves disease or Hashimoto thyroiditis are more likely than age-matched controls to have thyroid antibodies before clinical diagnosis and to measure the timing of antibody seroconversion.

Methods: This was a nested case-control study using the Department of Defense Serum Repository and the Defense Medical Surveillance System, 1998-2007. We assessed thyroid antibodies in the serum of 522 female, active-duty, military personnel including: 87 Graves disease cases, 87 Hashimoto thyroiditis cases, and 348 age matched controls. One serum sample was available at the time of the clinical diagnosis (±6 months); three additional samples were retrieved from the repository up to 7 yr before the clinical diagnosis, for a total of 2088 samples.

Results: In Hashimoto thyroiditis, TPO antibodies were found in about 66% of the cases at all time points. Tg antibodies showed a similar stationary trend, at a lower prevalence of about 53%at all time points. No TSH-R antibodies were found. In Graves disease, TPO antibodies gradually increased from 31% at 5-7 yr prior to diagnosis to 57% at diagnosis and Tg antibodies from 18 to 47%. TSH-R antibodies were present before diagnosis and showed an increasing prevalence from 2, 7, 20, to 55%.

Conclusions: Antibodies to Tg, TPO, and TSH-R precede by years the development of the diagnostic autoimmune thyroid diseases phenotype. Overall, the presence of thyroid antibodies in apparently healthy individuals should not be neglected.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Antibody positivity at each serum collection time point. Abs, Antibodies; HT, Hashimoto thyroiditis; GD, Graves disease; C, control. No control or Hashimoto thyroiditis case was TSH-R antibody positive.
Fig. 2.
Fig. 2.
Odds ratio comparing antibody positivity in Graves disease or Hashimoto thyroiditis cases and matched controls at each serum collection time point. Odds rations calculated using conditional logistic regression accounting for matching factors and race/ethnicity. Abs, Antibodies.

References

    1. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. 2002. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499 - PubMed
    1. Jacobson DL, Gange SJ, Rose NR, Graham NM. 1997. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223–243 - PubMed
    1. Yeatts RP. 2005. Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc 103:368–411 - PMC - PubMed
    1. Burman KD. 1997. Thyroid disease and osteoporosis. Hosp Pract (Minneap) 32:71–73, 78–85; discussion 85–86 - PubMed
    1. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J. 2010. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365–1374 - PMC - PubMed

Publication types